Grace E. DiDomenico

Grace E. DiDomenico

Auto-generated profile, based on publicly available information

Grace E. DiDomenico

Lifespan Brain Institute, CHOP and Penn Medicine, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
RBRan Barzilay
Ran Barzilay
TMTyler M. Moore
Tyler M. Moore
DGDavid M. Greenberg
David M. Greenberg
GDGrace E. DiDomenico
Grace E. DiDomenico
LBLily A. Brown
Lily A. Brown
RGRaquel E. Gur
Raquel E. Gur
COVID-19 pandemic is a global calamity posing an unprecedented opportunity to study resilience. We developed a brief resilience survey probing self-reliance, emotion-regulation, interpersonal-relationship patterns and neighborhood-environment, and applied it online during the acute COVID-19 outbreak (April 6–15, 2020), on a crowdsourcing research website (www.covid19resilience.org) advertised through social media. We evaluated level of stress (worries) regarding COVID-19: (1) contracting, (2) dying from, (3) currently having, (4) family member contracting, (5) unknowingly infecting others with (6) experiencing significant financial burden following. Anxiety (GAD7) and depression (PHQ2) were measured. Totally, 3042 participants (n = 1964 females, age range 18–79, mean age = 39) completed the resilience and COVID-19-related stress survey and 1350 of them (mean age = 41, SD = 13; n = 997 females) completed GAD7 and PHQ2. Participants significantly endorsed more distress about family contracting COVID-19 (48.5%) and unknowingly infecting others (36%), than getting COVID-19 themselves (19.9%), p < 0.0005 covarying for demographics and proxy COVID-19 exposures like getting tested and knowing infected individuals. Patterns of COVID-19 related worries, rates of anxiety (GAD7 > 10, 22.2%) and depression (PHQ2 > 2, 16.1%) did not differ between healthcare providers and non-healthcare providers. Higher resilience scores were associated with lower COVID-19 related worries (main effect F1,3054 = 134.9; p < 0.00001, covarying for confounders). Increase in 1 SD on resilience score was associated with reduced rate of anxiety (65%) and depression (69%), across healthcare and non-healthcare professionals. Findings provide empirical evidence on mental health associated with COVID-19 outbreak in a large convenience sample, setting a stage for longitudinal studies evaluating mental health trajectories following COVID-19 pandemic.

6 July 2023 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
JGJoshua H. Gordon
Joshua H. Gordon
KTKate T Tran
Kate T Tran
EVElina Visoki
Elina Visoki
SAStirling T. Argabright
Stirling T. Argabright
GDGrace E. DiDomenico
Grace E. DiDomenico
RBRan Barzilay
Ran Barzilay

20 August 2021 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
SAStirling T. Argabright
Stirling T. Argabright
EVElina Visoki
Elina Visoki
TMTyler M. Moore
Tyler M. Moore
DRDallas T. Ryan
Dallas T. Ryan
GDGrace E. DiDomenico
Grace E. DiDomenico
RBRan Barzilay
Ran Barzilay


25 April 2017 in Teaching Education
Verified
Journal Article
Closed access
SKSandra L. Kerr
Sandra L. Kerr
LLLisa J. Lucas
Lisa J. Lucas
GDGrace E. DiDomenico
Grace E. DiDomenico
VMVipanchi Mishra
Vipanchi Mishra
BSBrian J. Stanton
Brian J. Stanton
GTGabriella M. Terry
Gabriella M. Terry

14 February 2022 in Journal of Sleep Research
Verified
Journal Article
Open access
PDF file
LBLily Brown
Lily Brown
GHGabriella E. Hamlett
Gabriella E. Hamlett
YZYiqin Zhu
Yiqin Zhu
JWJoshua F. Wiley
Joshua F. Wiley
TMTyler M. Moore
Tyler M. Moore
RBRan Barzilay
Ran Barzilay
Summary: The coronavirus disease 2019 (COVID‐19) pandemic resulted in significant increases in insomnia, with up to 60% of people reporting increased insomnia. However, it is unclear whether exposure to risk factors for the virus or worries about COVID‐19 are more strongly associated with insomnia. Using a three‐part survey over the course of the first 6 months of the pandemic, we evaluated associations between COVID‐19 exposures, COVID‐19 worries, and insomnia. We hypothesised that COVID‐19‐related worries and exposure to risk of COVID‐19 would predict increases in insomnia. Participants (N = 3,560) completed a survey at three time‐points indicating their exposures to COVID‐19 risk factors, COVID‐19‐related worries, and insomnia. COVID‐19 worry variables were consistently associated with greater insomnia severity, whereas COVID‐19 exposure variables were not. COVID‐19 worries decreased significantly over time, and there were significant interactions between change in COVID‐19 worries and change in insomnia severity over time. Individuals who experienced increases in COVID‐19 worries also experienced increases in insomnia severity. Changes in worry during the COVID‐19 pandemic were associated with changes in insomnia; worries about COVID‐19 were a more consistent predictor of insomnia than COVID‐19 exposures. Evidence‐based treatments targeting virus‐related worries may improve insomnia during this and future calamities.